BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bock J, Liebisch G, Schweimer J, Schmitz G, Rogler G. Exogenous sphingomyelinase causes impaired intestinal epithelial barrier function. World J Gastroenterol 2007; 13(39): 5217-5225 [PMID: 17876892 DOI: 10.3748/wjg.v13.i39.5217] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 24] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Alhouayek M, Ameraoui H, Muccioli GG. Bioactive lipids in inflammatory bowel diseases - From pathophysiological alterations to therapeutic opportunities. Biochim Biophys Acta Mol Cell Biol Lipids 2021;1866:158854. [PMID: 33157277 DOI: 10.1016/j.bbalip.2020.158854] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Pastorelli L, De Salvo C, Mercado JR, Vecchi M, Pizarro TT. Central role of the gut epithelial barrier in the pathogenesis of chronic intestinal inflammation: lessons learned from animal models and human genetics. Front Immunol. 2013;4:280. [PMID: 24062746 DOI: 10.3389/fimmu.2013.00280] [Cited by in Crossref: 245] [Cited by in F6Publishing: 237] [Article Influence: 27.2] [Reference Citation Analysis]
3 Huang FC. The Role of Sphingolipids on Innate Immunity to Intestinal Salmonella Infection. Int J Mol Sci 2017;18:E1720. [PMID: 28783107 DOI: 10.3390/ijms18081720] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
4 Bryan PF, Karla C, Edgar Alejandro MT, Sara Elva EP, Gemma F, Luz C. Sphingolipids as Mediators in the Crosstalk between Microbiota and Intestinal Cells: Implications for Inflammatory Bowel Disease. Mediators Inflamm. 2016;2016:9890141. [PMID: 27656050 DOI: 10.1155/2016/9890141] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
5 Andersson D, Kotarsky K, Wu J, Agace W, Duan RD. Expression of alkaline sphingomyelinase in yeast cells and anti-inflammatory effects of the expressed enzyme in a rat colitis model. Dig Dis Sci. 2009;54:1440-1448. [PMID: 18989780 DOI: 10.1007/s10620-008-0509-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
6 Diesner SC, Förster-Waldl E, Olivera A, Pollak A, Jensen-Jarolim E, Untersmayr E. Perspectives on immunomodulation early in life. Pediatr Allergy Immunol 2012;23:210-23. [PMID: 22299601 DOI: 10.1111/j.1399-3038.2011.01259.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
7 Meiners J, Palmieri V, Klopfleisch R, Ebel JF, Japtok L, Schumacher F, Yusuf AM, Becker KA, Zöller J, Hose M, Kleuser B, Hermann DM, Kolesnick RN, Buer J, Hansen W, Westendorf AM. Intestinal Acid Sphingomyelinase Protects From Severe Pathogen-Driven Colitis. Front Immunol 2019;10:1386. [PMID: 31275322 DOI: 10.3389/fimmu.2019.01386] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
8 Li Y, Nicholson RJ, Summers SA. Ceramide signaling in the gut. Mol Cell Endocrinol 2022;544:111554. [PMID: 34998898 DOI: 10.1016/j.mce.2022.111554] [Reference Citation Analysis]
9 Tefas C, Ciobanu L, Tanțău M, Moraru C, Socaciu C. The potential of metabolic and lipid profiling in inflammatory bowel diseases: A pilot study. Bosn J Basic Med Sci 2020;20:262-70. [PMID: 31368421 DOI: 10.17305/bjbms.2019.4235] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Li Z, Kabir I, Tietelman G, Huan C, Fan J, Worgall T, Jiang XC. Sphingolipid de novo biosynthesis is essential for intestine cell survival and barrier function. Cell Death Dis 2018;9:173. [PMID: 29415989 DOI: 10.1038/s41419-017-0214-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
11 Zhang Y, Duan RD. Boswellic acid inhibits expression of acid sphingomyelinase in intestinal cells. Lipids Health Dis 2009;8:51. [PMID: 19951413 DOI: 10.1186/1476-511X-8-51] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
12 Lallès JP, Lessard M, Boudry G. Intestinal barrier function is modulated by short-term exposure to fumonisin B₁ in Ussing chambers. Vet Res Commun 2009;33:1039-43. [PMID: 19626452 DOI: 10.1007/s11259-009-9310-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
13 Custers, Emma EM, Kiliaan, Amanda J. Dietary lipids from body to brain. Prog Lipid Res 2021;85:101144. [PMID: 34915080 DOI: 10.1016/j.plipres.2021.101144] [Reference Citation Analysis]
14 Pepper I, Zhao X. Alveolar epithelial cell integrity: A venerable target in the lung. Curr Top Membr 2019;84:187-216. [PMID: 31610863 DOI: 10.1016/bs.ctm.2019.07.002] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
15 Zhang P, Cheng Y, Duan RD. Ursolic acid inhibits acid sphingomyelinase in intestinal cells. Phytother Res 2013;27:173-8. [PMID: 22511398 DOI: 10.1002/ptr.4709] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
16 Parveen F, Bender D, Law SH, Mishra VK, Chen CC, Ke LY. Role of Ceramidases in Sphingolipid Metabolism and Human Diseases. Cells 2019;8:E1573. [PMID: 31817238 DOI: 10.3390/cells8121573] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 7.7] [Reference Citation Analysis]
17 Bauer J, Liebisch G, Hofmann C, Huy C, Schmitz G, Obermeier F, Bock J. Lipid alterations in experimental murine colitis: role of ceramide and imipramine for matrix metalloproteinase-1 expression. PLoS One 2009;4:e7197. [PMID: 19787068 DOI: 10.1371/journal.pone.0007197] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
18 Abdel Hadi L, Di Vito C, Riboni L. Fostering Inflammatory Bowel Disease: Sphingolipid Strategies to Join Forces. Mediators Inflamm 2016;2016:3827684. [PMID: 26880864 DOI: 10.1155/2016/3827684] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 5.2] [Reference Citation Analysis]
19 Kim YR, Volpert G, Shin KO, Kim SY, Shin SH, Lee Y, Sung SH, Lee YM, Ahn JH, Pewzner-Jung Y, Park WJ, Futerman AH, Park JW. Ablation of ceramide synthase 2 exacerbates dextran sodium sulphate-induced colitis in mice due to increased intestinal permeability. J Cell Mol Med 2017;21:3565-78. [PMID: 28699686 DOI: 10.1111/jcmm.13267] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
20 Duan RD. Physiological functions and clinical implications of sphingolipids in the gut. J Dig Dis 2011;12:60-70. [PMID: 21401891 DOI: 10.1111/j.1751-2980.2011.00481.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
21 Rohrhofer J, Zwirzitz B, Selberherr E, Untersmayr E. The Impact of Dietary Sphingolipids on Intestinal Microbiota and Gastrointestinal Immune Homeostasis. Front Immunol 2021;12:635704. [PMID: 34054805 DOI: 10.3389/fimmu.2021.635704] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
22 Ghezzal S, Postal BG, Quevrain E, Brot L, Seksik P, Leturque A, Thenet S, Carrière V. Palmitic acid damages gut epithelium integrity and initiates inflammatory cytokine production. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2020;1865:158530. [DOI: 10.1016/j.bbalip.2019.158530] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
23 Rimkute I, Thorsteinsson K, Henricsson M, Tenge VR, Yu X, Lin SC, Haga K, Atmar RL, Lycke N, Nilsson J, Estes MK, Bally M, Larson G. Histo-blood group antigens of glycosphingolipids predict susceptibility of human intestinal enteroids to norovirus infection. J Biol Chem 2020;295:15974-87. [PMID: 32913124 DOI: 10.1074/jbc.RA120.014855] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
24 Kurek K, Łukaszuk B, Piotrowska DM, Wiesiołek P, Chabowska AM, Zendzian-Piotrowska M. Metabolism, physiological role, and clinical implications of sphingolipids in gastrointestinal tract. Biomed Res Int 2013;2013:908907. [PMID: 24083248 DOI: 10.1155/2013/908907] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
25 Milard M, Penhoat A, Durand A, Buisson C, Loizon E, Meugnier E, Bertrand K, Joffre F, Cheillan D, Garnier L, Viel S, Laugerette F, Michalski M. Acute effects of milk polar lipids on intestinal tight junction expression: towards an impact of sphingomyelin through the regulation of IL-8 secretion? The Journal of Nutritional Biochemistry 2019;65:128-38. [DOI: 10.1016/j.jnutbio.2018.12.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
26 Boldyreva LV, Morozova MV, Saydakova SS, Kozhevnikova EN. Fat of the Gut: Epithelial Phospholipids in Inflammatory Bowel Diseases. Int J Mol Sci 2021;22:11682. [PMID: 34769112 DOI: 10.3390/ijms222111682] [Reference Citation Analysis]
27 Kolter T. A view on sphingolipids and disease. Chem Phys Lipids. 2011;164:590-606. [PMID: 21570958 DOI: 10.1016/j.chemphyslip.2011.04.013] [Cited by in Crossref: 64] [Cited by in F6Publishing: 59] [Article Influence: 5.8] [Reference Citation Analysis]